Clinical Trial

The First-In-Man Use of Coronary Sinus Balloon Pump in STEMI Patients Treated by Primary PCI

Study acronym: REVIVE-FIM
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multicenter clinical investigation aiming to evaluate the safety and efficacy of the coronary sinus balloon pump in its first application in patients with acute ST-segment elevation myocardial infarction (STEMI).
Trial Details
NCT Number NCT07082153
Lead Sponsor Shanghai MicroPort Rhythm MedTech Co., Ltd.
Conditions STEMI
Enrollment 10 participants
Start Date 2025-08-12
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-03-03 (estimated)
Updated on ClinicalTrials.gov 2025-07-24